In this session panelists will first explore the economic and financial toll of health inequities in hindering access to affordable health care, including drugs and treatments as well as participation in clinical trials. Conversely, they will review measures that policymakers and industry—particularly within the C-suite—can take to effect meaningful change in making the health-care and research ecosystem more equitable and affordable. Participants will be encouraged to learn the role new investments can assume in driving meaningful change from the top decision makers. 

Moderator

Nicholas St. Fleur

Science Reporter, Associate Editorial Director of Events and Host of Color Code Podcast, STAT

Speakers

Bechara Choucair

Executive Vice President and Chief Health Officer, Kaiser Permanente

Stephanie Davis

Managing Director, US Healthcare Technology and Digital Health, Barclays

Darrick Hamilton

Founding Director, Institute on Race, Power and Political Economy, The New School

Deena Shakir

General Partner, Lux Capital

Ramita Tandon

Chief Clinical Trials Officer, Walgreens Boots Alliance